Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 13, Number 7, 1998

Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas
pp. 735-747(13)
Authors: Jiang, J-D; Roboz, J; Weisz, I; Deng, L; Ma, L; Holland, JF; George Bekesi, J

Favourites:
ADD

Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA
pp. 749-768(20)
Authors: Henderson, ND; Lacy, SM; O'Hare, CC; Hartley, JA; McClean, S; Wakelin, LPG; Kelland, LR; Robins, DJ

Favourites:
ADD

In vitro and in vivo growth inhibition of cancer cells by adamantylmaleimide derivatives
pp. 779-796(18)
Authors: Wang, J-J; Chern, Y-T; Liu, T-Y; Chi, C-W

Favourites:
ADD

The effect of 12-alkoxy modification on the in vitro antileukaemic activity of N-methyl 2,3,8,9-tetramethoxybenzo[c]phenanthridinium salts
pp. 797-813(17)
Authors: Mackay, SP; Comoe, L; Desoize, B; Duval, O; Jardillier, J-C; Waigh, RD

Favourites:
ADD

Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols
pp. 825-835(11)
Authors: Dorr, RT; Bellamy, W; Liddil, JD; Baker, A; Bair, KW

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more